{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:18:00Z","timestamp":1792793880570,"version":"4.5.0"},"reference-count":120,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["26672"],"award-info":[{"award-number":["26672"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"award":["26672"],"award-info":[{"award-number":["26672"]}],"id":[{"id":"https:\/\/ror.org\/05v75r592","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Radiotherapy outcomes are determined by the balance between tumor control and normal tissue toxicity, both of which exhibit significant interpatient variability. While radiogenomic and molecular approaches have identified determinants of radiosensitivity, their predictive performance remains limited when used in isolation. Methods: This review provides a comprehensive synthesis of functional assays, genomic biomarkers, and integrative models used to assess radiosensitivity, including radiation-induced lymphocyte apoptosis (RILA), chromosomal radiosensitivity assays, micronucleus formation, \u03b3-H2AX foci kinetics, comet assays, clonogenic survival, and patient-derived organoids, alongside genomic and molecular predictors of tumor response such as hypoxia signatures and gene expression-based models (e.g., RSI and GARD). Results: Functional assays provide direct phenotypic assessment of radiation response, capturing DNA repair capacity, chromosomal stability, apoptosis, and tissue regenerative potential, and have shown associations in several studies with normal tissue toxicity across clinical settings. Tumor radiosensitivity is influenced by intrinsic cellular factors and microenvironmental conditions, including hypoxia and genomic instability. Integrative approaches combining functional, genomic, and clinical data show increasing potential for improving predictive accuracy. Conclusions: Radiosensitivity should be considered a systems-level phenotype requiring multi-dimensional assessment. Conceptual frameworks that integrate tumor and normal tissue responses within a unified modeling approach, supported by measurable biological and clinical parameters, represent a promising direction for clinically actionable precision radiotherapy. The integration of functional assays with genomic and clinical modeling frameworks represents a promising strategy for advancing personalized radiotherapy and improving therapeutic outcomes.<\/jats:p>","DOI":"10.3390\/cancers18111823","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:45:08Z","timestamp":1780404308000},"page":"1823","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["From Cellular Radiosensitivity to Precision Radiotherapy: Integrating Functional Assays, Genomics, and Clinical Modeling"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7614-9499","authenticated-orcid":false,"given":"Angeliki","family":"Gkikoudi","sequence":"first","affiliation":[{"name":"DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece"},{"name":"Laboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research \u201cDemokritos\u201d, 15341 Agia Paraskevi, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Triantopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research \u201cDemokritos\u201d, 15341 Agia Paraskevi, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eygenia","family":"Markellou","sequence":"additional","affiliation":[{"name":"DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Xynou","sequence":"additional","affiliation":[{"name":"Laboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research \u201cDemokritos\u201d, 15341 Agia Paraskevi, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0596-2945","authenticated-orcid":false,"given":"Spyridon N.","family":"Vasilopoulos","sequence":"additional","affiliation":[{"name":"DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4850-9183","authenticated-orcid":false,"given":"Marios","family":"Myronakis","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4924-9013","authenticated-orcid":false,"given":"Evagelia C.","family":"Laiakis","sequence":"additional","affiliation":[{"name":"Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6571-9433","authenticated-orcid":false,"given":"Kiki","family":"Theodorou","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Faculty of Medicine, University of Thessaly, 41500 Larissa, Greece"},{"name":"Innovation and Research, King Faisal Specialist Hospital & Research Centre, Riyadh 11211, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-5072","authenticated-orcid":false,"given":"Georgia I.","family":"Terzoudi","sequence":"additional","affiliation":[{"name":"Laboratory of Health Physics, Radiobiology & Cytogenetics, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research \u201cDemokritos\u201d, 15341 Agia Paraskevi, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-0010","authenticated-orcid":false,"given":"Alexandros G.","family":"Georgakilas","sequence":"additional","affiliation":[{"name":"DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou Campus, 15780 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1053-4296(05)80034-7","article-title":"Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury","volume":"4","author":"Bentzen","year":"1994","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3857\/roj.2014.32.3.103","article-title":"Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials","volume":"32","author":"Kim","year":"2014","journal-title":"Radiat. Oncol. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20150582","article-title":"How cancer cells hijack DNA double-strand break repair pathways to gain genomic instability","volume":"471","author":"Jeggo","year":"2015","journal-title":"Biochem. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.semradonc.2017.04.001","article-title":"Mechanisms of Normal Tissue Injury From Irradiation","volume":"27","author":"Citrin","year":"2017","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.radonc.2016.06.017","article-title":"Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients","volume":"121","author":"Andreassen","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nrc2587","article-title":"Normal tissue reactions to radiotherapy: Towards tailoring treatment dose by genotype","volume":"9","author":"Barnett","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: Making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2159-8290.CD-13-0197","article-title":"Radiogenomics: Using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy","volume":"4","author":"Kerns","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2019.07.026","article-title":"The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists","volume":"105","author":"Bergom","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(11)70302-3","article-title":"Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study","volume":"13","author":"Barnett","year":"2012","journal-title":"Lancet. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0360-3016(97)00038-2","article-title":"Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes","volume":"38","author":"Ozsahin","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","article-title":"CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: A prospective study in 399 patients","volume":"11","author":"Ozsahin","year":"2005","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2011.09.021","article-title":"A standardized G2-assay for the prediction of individual radiosensitivity","volume":"101","author":"Pantelias","year":"2011","journal-title":"Radiother. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1051\/radiopro\/2025004","article-title":"Gamma-H2AX as a biomarker to assess individual radiosensitivity for radiopharmaceutical therapy in cancer patients: A systematic review","volume":"60","author":"Kisnanto","year":"2025","journal-title":"Radioprotection"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13014-024-02545-z","article-title":"Toxicity assessment following conventional radiation therapy and pulsed low dose rate radiation therapy: An in vivo animal study","volume":"19","author":"Salem","year":"2024","journal-title":"Radiat. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1667\/0033-7587(2003)159[0713:RMFIPB]2.0.CO;2","article-title":"Radiation-induced micronucleus frequency in peripheral blood lymphocytes is correlated with normal tissue damage in patients with cervical carcinoma undergoing radiotherapy","volume":"159","author":"Widel","year":"2003","journal-title":"Radiat. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nprot.2006.5","article-title":"The comet assay: A method to measure DNA damage in individual cells","volume":"1","author":"Olive","year":"2006","journal-title":"Nat. Protoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/0008-5472.CAN-19-0312","article-title":"Organoids Reveal That Inherent Radiosensitivity of Small and Large Intestinal Stem Cells Determines Organ Sensitivity","volume":"80","author":"Martin","year":"2020","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wu, B., Zhao, A., Chen, W., Zhou, Y., Zhang, W., Zhang, Y., Hou, Q., Yao, N., Zhang, S., and Duan, J. (2025). Microbiota-mediated modulation of radiosensitivity: Mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1689735"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kunachowicz, D., Tomecka, P., S\u0119dzik, M., Kalinin, J., Ku\u017anicki, J., and Rembia\u0142kowska, N. (2025). Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies. Cells, 14.","DOI":"10.3390\/cells14141057"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101164","DOI":"10.1016\/j.neo.2025.101164","article-title":"Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment","volume":"64","author":"Ma","year":"2025","journal-title":"Neoplasia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrclinonc.2015.120","article-title":"Opportunities and challenges of radiotherapy for treating cancer","volume":"12","author":"Schaue","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-024-02270-2","article-title":"Genomic predictors of radiation response: Recent progress towards personalized radiotherapy for brain metastases","volume":"10","author":"Harary","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2017.05.023","article-title":"Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach","volume":"403","author":"Pavlopoulou","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_26","first-page":"104720","article-title":"Tumour and normal tissue radiosensitivity: 2025 update","volume":"29","author":"Lapierre","year":"2025","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41418-023-01230-0","article-title":"Ionizing radiation-induced mitophagy promotes ferroptosis by increasing intracellular free fatty acids","volume":"30","author":"Yang","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2008.10.039","article-title":"Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients","volume":"74","author":"Schnarr","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1158\/1078-0432.CCR-08-0700","article-title":"Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy","volume":"14","author":"Azria","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"a001180","DOI":"10.1101\/cshperspect.a001180","article-title":"Pathologies associated with the p53 response","volume":"2","author":"Gudkov","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semradonc.2014.07.007","article-title":"Radiation and inflammation","volume":"25","author":"Schaue","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ebiom.2019.02.031","article-title":"RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study","volume":"41","author":"Mirjolet","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41598-024-81450-7","article-title":"Assessment of the predictive power the radiation-induced lymphocyte apoptosis method in prostate cancer patients","volume":"15","author":"Farkas","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1158\/1078-0432.CCR-18-0777","article-title":"Association of CD4+ Radiation-Induced Lymphocyte Apoptosis with Fibrosis and Telangiectasia after Radiotherapy in 272 Breast Cancer Patients with >10-Year Follow-up","volume":"25","author":"Veldwijk","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/095530099140744","article-title":"Increased chromosomal radiosensitivity in breast cancer patients: A comparison of two assays","volume":"75","author":"Scott","year":"1999","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-8140(99)00158-9","article-title":"Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer","volume":"55","author":"Barber","year":"2000","journal-title":"Radiother. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2003.10.001","article-title":"Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer","volume":"69","author":"Hoeller","year":"2003","journal-title":"Radiother. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ijrobp.2004.12.027","article-title":"Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes","volume":"62","author":"Claes","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41598-025-31033-x","article-title":"Evaluation of predictive biomarkers for late radiation toxicity in breast cancer patients","volume":"16","author":"Linares","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ki\u0161onas, J., Venius, J., Sevriukova, O., Grybauskas, M., Dabkevi\u010dien\u0117, D., Burneckis, A., and Rotomskis, R. (2022). Individual Radiosensitivity as a Risk Factor for the Radiation-Induced Acute Radiodermatitis. Life, 12.","DOI":"10.3390\/life12010020"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","article-title":"Cytokinesis-block micronucleus cytome assay","volume":"2","author":"Fenech","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00204-021-03113-0","article-title":"Inter-laboratory automation of the in vitro micronucleus assay using imaging flow cytometry and deep learning","volume":"95","author":"Wills","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1084\/jem.103.5.653","article-title":"Action of x-rays on mammalian cells","volume":"103","author":"Puck","year":"1956","journal-title":"J. Exp. Med."},{"key":"ref_45","first-page":"624","article-title":"Eric J. Hall and Amato J. Giaccia: Radiobiology for the radiologist","volume":"Volume 41","author":"Douglass","year":"2019","journal-title":"Australasian Physical & Engineering Sciences in Medicine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0360-3016(81)90377-1","article-title":"Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy","volume":"7","author":"Fertil","year":"1981","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0360-3016(95)00068-A","article-title":"Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer","volume":"32","author":"Brock","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0360-3016(99)00409-5","article-title":"Correlation between normal tissue complications and in vitro radiosensitivity of skin fibroblasts derived from radiotherapy patients treated for variety of tumors","volume":"46","author":"Alsbeih","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0167-8140(97)01933-6","article-title":"In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer","volume":"43","author":"Rudat","year":"1997","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4161\/cc.9.4.10764","article-title":"\u03b3H2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization","volume":"9","author":"Shibata","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijrobp.2003.09.028","article-title":"Phosphorylation of histone H2AX as a measure of radiosensitivity","volume":"58","author":"Olive","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_53","first-page":"49","article-title":"\u03b3H2AX foci as a measure of DNA damage: A computational approach to automatic analysis","volume":"711","author":"Ivashkevich","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1002\/ijc.25953","article-title":"Prolonged expression of the \u03b3-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment","volume":"129","author":"Bourton","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2016.09.010","article-title":"Compromized DNA repair as a basis for identification of cancer radiotherapy patients with extreme radiosensitivity","volume":"383","author":"Lobachevsky","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S779","DOI":"10.1016\/j.ijrobp.2014.05.2255","article-title":"Gamma-H2AX as a Predictive Biomarker of Individual Radiosensitivity","volume":"90","author":"Leong","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/jrr\/rrad079","article-title":"Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay","volume":"64","author":"Someya","year":"2023","journal-title":"J. Radiat. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijrobp.2021.08.020","article-title":"Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity Than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients","volume":"112","author":"Nuijens","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-024-02501-x","article-title":"Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: Lower toxicity rates reduce the predictive value of \u03b3-H2AX foci decay ratio in patients undergoing pelvic radiotherapy","volume":"19","author":"Nuijens","year":"2024","journal-title":"Radiat. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/sj.bjc.6605666","article-title":"H2AX phosphorylation screen of cells from radiosensitive cancer patients reveals a novel DNA double-strand break repair cellular phenotype","volume":"102","author":"Vasireddy","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_61","first-page":"571","article-title":"Prediction of late normal tissue complications in RT treated gynaecological cancer patients: Potential of the \u03b3-H2AX foci assay and association with chromosomal radiosensitivity","volume":"23","author":"Werbrouck","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.21037\/jgo-24-488","article-title":"Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: A potential response predictor","volume":"15","author":"Toapichattrakul","year":"2024","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00432-024-05681-x","article-title":"Upregulation of the histone \u03b3-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma","volume":"150","author":"Knipper","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-1110(94)00013-3","article-title":"The comet assay: A comprehensive review","volume":"339","author":"Fairbairn","year":"1995","journal-title":"Mutat. Res. Rev. Genet. Toxicol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/mutage\/gem054","article-title":"Potential use of the comet assay in the clinical management of cancer","volume":"23","author":"McKenna","year":"2008","journal-title":"Mutagenesis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<83::AID-IJC16>3.0.CO;2-8","article-title":"Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: Defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients","volume":"83","author":"Alapetite","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004110000087","article-title":"Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay","volume":"40","author":"Bauch","year":"2001","journal-title":"Radiat. Environ. Biophys."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"503371","DOI":"10.1016\/j.mrgentox.2021.503371","article-title":"Radiosensitivity of radiotherapy patients: The effect of individual DNA repair capacity","volume":"867","author":"Ocolotobiche","year":"2021","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0360-3016(02)04415-2","article-title":"Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy","volume":"55","author":"Popanda","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5114\/pjp.2018.81230","article-title":"Comet assay is not useful to predict normal tissue response after radiochemotherapy in cervical and larynx cancer patients","volume":"69","author":"Adamczyk","year":"2018","journal-title":"Pol. J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/MB:26:3:249","article-title":"The comet assay for DNA damage and repair: Principles, applications, and limitations","volume":"26","author":"Collins","year":"2004","journal-title":"Mol. Biotechnol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wang, Y., Li, Y., Sheng, Z., Deng, W., Yuan, H., Wang, S., and Liu, Y. (2022). Advances of Patient-Derived Organoids in Personalized Radiotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.888416"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yin, D., Hong, X., Wang, X., Ding, W., Wang, C., Qian, J., Zhou, Y., Sun, C., and Wu, Z. (2025). Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32120680"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","article-title":"Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation","volume":"25","author":"Pasch","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_76","first-page":"100829","article-title":"Radiation response assessment of organoids derived from patients with pancreatic cancer","volume":"48","author":"Raymakers","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2016.01.035","article-title":"Radiogenomics\u2014Current status, challenges and future directions","volume":"382","author":"Andreassen","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"109806","DOI":"10.1016\/j.radonc.2023.109806","article-title":"Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer","volume":"187","author":"Jandu","year":"2023","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"21306","DOI":"10.1038\/s41598-022-25328-6","article-title":"Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer","volume":"12","author":"Brengues","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13205-013-0135-3","article-title":"Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity","volume":"4","author":"Alsbeih","year":"2014","journal-title":"3 Biotech"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2015.04.011","article-title":"XRCC Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients","volume":"92","author":"Seibold","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12967-022-03561-x","article-title":"Germline genetic biomarkers to stratify patients for personalized radiation treatment","volume":"20","author":"Deichaite","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41416-021-01670-w","article-title":"A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositis","volume":"126","author":"Schack","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2021.03.024","article-title":"Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity","volume":"159","author":"Franco","year":"2021","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1088\/0031-9155\/45\/2\/303","article-title":"Tumour control probability: A formulation applicable to any temporal protocol of dose delivery","volume":"45","author":"Zaider","year":"2000","journal-title":"Phys. Med. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br. J. Radiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/bjc.1993.434","article-title":"Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix","volume":"68","author":"West","year":"1993","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00373-9","article-title":"Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers","volume":"46","author":"West","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-8140(98)00129-7","article-title":"Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck","volume":"50","author":"Overgaard","year":"1999","journal-title":"Radiother. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: Adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"100764","DOI":"10.1016\/j.xgen.2025.100764","article-title":"Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures","volume":"5","author":"Hartley","year":"2025","journal-title":"Cell Genom."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-06-3322","article-title":"Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers","volume":"67","author":"Winter","year":"2007","journal-title":"Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","article-title":"A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer","volume":"19","author":"Eustace","year":"2013","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1158\/0008-5472.CAN-05-0656","article-title":"Prediction of Radiation Sensitivity Using a Gene Expression Classifier","volume":"65","author":"Eschrich","year":"2005","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Bleaney, C.W., Abdelaal, H., Reardon, M., Anandadas, C., Hoskin, P., Choudhury, A., and Forker, L. (2024). Clinical Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy: A Systematic Review. Cancers, 16.","DOI":"10.3390\/cancers16101942"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1158\/1078-0432.CCR-12-0891","article-title":"Validation of a radiosensitivity molecular signature in breast cancer","volume":"18","author":"Eschrich","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.18632\/oncotarget.5437","article-title":"The radiosensitivity index predicts for overall survival in glioblastoma","volume":"6","author":"Ahmed","year":"2015","journal-title":"Oncotarget"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ijrobp.2009.06.014","article-title":"A gene expression model of intrinsic tumor radiosensitivity: Prediction of response and prognosis after chemoradiation","volume":"75","author":"Eschrich","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2015.06.021","article-title":"Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer","volume":"93","author":"Fulp","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijrobp.2019.11.013","article-title":"Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy","volume":"106","author":"Mohammadi","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clon.2023.02.018","article-title":"Radiosensitivity Index is Not Fit to be Used for Dose Adjustments: A Pan-Cancer Analysis","volume":"35","author":"Mistry","year":"2023","journal-title":"Clin. Oncol. R Coll. Radiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1470-2045(21)00411-3","article-title":"Genomic-adjusted radiation dose to personalise radiotherapy","volume":"22","author":"Poortmans","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15406\/ijrrt.2017.02.00013","article-title":"An Overview on the Clinical Application of Radiobiological Modeling in Radiation Therapy of Cancer","volume":"2","author":"Mesbahi","year":"2017","journal-title":"Int. J. Radiol. Radiat. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.seminoncol.2019.07.006","article-title":"Normal tissue complication probability (NTCP) models for modern radiation therapy","volume":"46","author":"Palma","year":"2019","journal-title":"Semin. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00285-008-0222-y","article-title":"Linear quadratic and tumour control probability modelling in external beam radiotherapy","volume":"58","author":"McAneney","year":"2009","journal-title":"J. Math. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e104408","DOI":"10.1136\/bmjopen-2025-104408","article-title":"Protocol for the PROSECCA study: A new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data","volume":"16","author":"Nailon","year":"2026","journal-title":"BMJ Open"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Isaksson, L.J., Pepa, M., Zaffaroni, M., Marvaso, G., Alterio, D., Volpe, S., Corrao, G., Augugliaro, M., Starzy\u0144ska, A., and Leonardi, M.C. (2020). Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00790"},{"key":"ref_111","first-page":"e92964","article-title":"AI in Radiation Oncology: A Comprehensive Review of Current Applications and Future Directions","volume":"17","author":"Zafar","year":"2025","journal-title":"Cureus"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10238-025-01965-9","article-title":"AI-driven multi-omics integration in precision oncology: Bridging the data deluge to clinical decisions","volume":"26","author":"Hsu","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Ozaki, Y., Broughton, P., Abdollahi, H., Valafar, H., and Blenda, A.V. (2024). Integrating Omics Data and AI for Cancer Diagnosis and Prognosis. Cancers, 16.","DOI":"10.20944\/preprints202406.0657.v1"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.6004\/jnccn.2015.0151","article-title":"Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors","volume":"13","author":"Grossman","year":"2015","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Investig."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Casagrande, G.M.S., Silva, M.O., and Reis, R.M. (2023). Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032505"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Palieri, R., De Luca, M., Balestra, F., Panzetta, G., Lotesoriere, C., Rizzi, F., Ricci, A.D., Mastrogiacomo, R., Curri, M.L., and Laghi, L.A. (2025). Liquid biopsy in gastrointestinal oncology: Clinical applications and translational integration of ctDNA, CTCs, and sEVs. Oncol. Rev., 19.","DOI":"10.3389\/or.2025.1702932"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"ref_120","first-page":"37","article-title":"Charged particles in radiation oncology. Nature reviews","volume":"7","author":"Durante","year":"2010","journal-title":"Clin. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1823\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:30:23Z","timestamp":1780720223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":120,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111823"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111823","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}